Cara Therapeutics, Inc. - Special Call Transcript
Good morning, and welcome to Cara Therapeutics Oral KORSUVA CKD-associated Pruritus Phase II Top Line Data Conference Call. (Operator Instructions) Please be advised that this call is being recorded at Cara's request.
I would now like to turn the call over to the Cara team. Please proceed.
Good morning. This is Jane with Stern Investor Relations, and welcome to Cara Therapeutics Oral KORSUVA CKD-associated Pruritus Phase II Top Line Data Conference Call. The news release became available at 7:00 a.m. Eastern Time today and can be found on our website at www.caratherapeutics.com. You may also listen to a live webcast and replay of today's call on the Investors section of the website.
I'll now turn the call over to Dr. Derek Chalmers, Cara President and CEO.
Thanks, Jane. Good morning
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |